Overexpression of ZEB2 is implicated in various malignant carcinomas, reflecting that ZEB2 promotes tumor metastasis, invasiveness and correlates with poor prognosis of human colorectal cancer, glioma, acute myeloid leukemia and small cell lung cancer [19,35–38]. This evidence concerns the gene ZEB2 and central nervous system cancer.